Optimum Investment Advisors’s Zomedica Corp. ZOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-20,000
Closed -$2.4K 651
2024
Q4
$2.4K Hold
20,000
﹤0.01% 577
2024
Q3
$2.74K Hold
20,000
﹤0.01% 590
2024
Q2
$2.92K Hold
20,000
﹤0.01% 583
2024
Q1
$2.92K Hold
20,000
﹤0.01% 590
2023
Q4
$4K Hold
20,000
﹤0.01% 566
2023
Q3
$3.34K Hold
20,000
﹤0.01% 633
2023
Q2
$4K Hold
20,000
﹤0.01% 621
2023
Q1
$4.23K Hold
20,000
﹤0.01% 637
2022
Q4
$3.26K Hold
20,000
﹤0.01% 653
2022
Q3
$4K Hold
20,000
﹤0.01% 684
2022
Q2
$4K Hold
20,000
﹤0.01% 722
2022
Q1
$7K Hold
20,000
﹤0.01% 697
2021
Q4
$6K Hold
20,000
﹤0.01% 727
2021
Q3
$10K Hold
20,000
﹤0.01% 690
2021
Q2
$17K Hold
20,000
0.01% 690
2021
Q1
$32K Buy
+20,000
New +$32.7K 0.01% 591

Other funds holding ZOM

Optimum Investment Advisors's ZOM Position: Q1 2025 in Review

Optimum Investment Advisors sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 20,000 shares — an estimated $2.4K sold.

Optimum Investment Advisors first reported a position in ZOM in Q1 2021 and held it in 16 quarters. The position peaked at $32K in Q1 2021. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • Optimum Investment Advisors reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • Optimum Investment Advisors sold 20,000 Zomedica Corp. shares in Q1 2025, an estimated $2.4K.
  • Optimum Investment Advisors first reported a position in Zomedica Corp. in Q1 2021 and held it in 16 quarters.
  • Optimum Investment Advisors's Zomedica Corp. position peaked at $32K in Q1 2021.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on Optimum Investment Advisors's 13F filing for Q1 2025, filed 30 Apr 2025.